# Teva Pharmaceutical Industries Limited (TEVA): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Teva Pharmaceutical Industries Limited (TEVA) is 61/100, ranked against 24,000+ stocks in 35 markets (Quality 52, Value 34, Momentum 69, each scored against its sector).

- StockRank: 61/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 52, Value 34, Momentum 69: each a 0-100 percentile within Healthcare.
- Position: #10,337 overall, #1,000 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 39.95 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 34.5M.

Source: https://moatmap.ai/stock/TEVA
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker